Tau protein aggregation associated with SARS-CoV-2 main protease
PLOS ONE · 21.08.2023 · 18 (8) · e0288138
DOI: 10.1371/journal.pone.0288138 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 21.08.2023. Verfasst von Raphael Josef Eberle und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological Information Processing (IBI-7: Structural Biochemistry), Forschungszentrum Jülich, Jülich, Germany. Hauptthemen laut MEDLINE: Coronavirus 3C Proteases, COVID-19, Protein Aggregates, tau Proteins. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Alzheimer's Association, Weston Brain Institute.
Abstract (Originalsprache)
The primary function of virus proteases is the proteolytic processing of the viral polyprotein. These enzymes can also cleave host cell proteins, which is important for viral pathogenicity, modulation of cellular processes, viral replication, the defeat of antiviral responses and modulation of the immune response. It is known that COVID-19 can influence multiple tissues or organs and that infection can damage the functionality of the brain in multiple ways. After COVID-19 infections, amyloid-β, neurogranin, tau and phosphorylated tau were detected extracellularly, implicating possible neurodegenerative processes. The present study describes the possible induction of tau aggregation by the SARS-CoV-2 3CL protease (3CL pro ) possibly relevant in neuropathology. Further investigations demonstrated that tau was proteolytically cleaved by the viral protease 3CL and, consequently, generated aggregates. However, more evidence is needed to confirm that COVID-19 is able to trigger neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biological Information Processing (IBI-7: Structural Biochemistry), Forschungszentrum Jülich, Jülich, Germany.
- Institute of Physical Biology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
- Molecular Proteomics Laboratory (MPL), BMFZ, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
- attyloid GmbH, Düsseldorf, Germany.
- JuStruct: Jülich Centre for Structural Biology, Forschungszentrum Jülich, Jülich, Germany.
ORCID-Profile: Raphael Josef Eberle, Mônika Aparecida Coronado, Ian Gering, Anja Stefanski, Kai Stühler, Victoria Kraemer-Schulien, Lara Blömeke, Oliver Bannach, Dieter Willbold
Förderung
- Deutsche Forschungsgemeinschaft
- Alzheimer's Association
- Weston Brain Institute
- Michael J. Fox Foundation for Parkinson's Research
- ALS Association
- Helmholtz-Gemeinschaft
Zitieren
APA
Eberle, R. J., Coronado, M. A., Gering, I., Sommerhage, S., Korostov, K., Stefanski, A., Stühler, K., Kraemer-Schulien, V., Blömeke, L., Bannach, O., & Willbold, D. (2023). Tau protein aggregation associated with SARS-CoV-2 main protease. PLOS ONE, 18(8), e0288138. https://doi.org/10.1371/journal.pone.0288138
Vancouver
Eberle RJ, Coronado MA, Gering I, Sommerhage S, Korostov K, Stefanski A, et al. Tau protein aggregation associated with SARS-CoV-2 main protease. PLOS ONE. 2023;18(8):e0288138. doi:10.1371/journal.pone.0288138
BibTeX
@article{Eberle2023,
author = {Eberle, Raphael Josef and Coronado, Mônika Aparecida and Gering, Ian and Sommerhage, Simon and Korostov, Karolina and Stefanski, Anja and Stühler, Kai and Kraemer-Schulien, Victoria and Blömeke, Lara and Bannach, Oliver and Willbold, Dieter},
title = {Tau protein aggregation associated with SARS-CoV-2 main protease},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {8},
pages = {e0288138},
doi = {10.1371/journal.pone.0288138}
}
EUVIMED